The role of surgery in cytologically positive pleural effusion in NSCLC Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors Year: 2003
Diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules Year: 2007
Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019
Correlations between the bronchoalveolar lavage cytology and lung function stage in newly diagnosed sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 538s Year: 2006
Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007
The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003
Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011
Diagnosis of malignant pleural effusions; cytology or biopsy? Source: Eur Respir J 2004; 24: Suppl. 48, 72s Year: 2004
Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009
Medical thoracoscopy for diagnosis of pleural effusion in cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
The value of sputum cytology in the diagnosis of lung malignancy Source: Eur Respir J 2007; 30: Suppl. 51, 429s Year: 2007
Comparison between bronchoscopy, closed (Abram’s) and medical thoracoscopic pleural biopsies in undiagnosed pleural effusions Source: International Congress 2016 – Pleural diseases Year: 2016
The value of cytology in pleural effusions vs histology by medical thoracoscopy Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 50s Year: 2006